121 related articles for article (PubMed ID: 8394950)
21. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro.
Weidner S; Neupert W; Goppelt-Struebe M; Rupprecht HD
Arthritis Rheum; 2001 Jul; 44(7):1698-706. PubMed ID: 11465722
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies.
Gans RO; Kuizinga MC; Goldschmeding R; Assmann K; Huysmans FT; Gerlag PG; Donker AJ; Hoorntje SJ
Nephron; 1993; 64(2):182-8. PubMed ID: 8321348
[TBL] [Abstract][Full Text] [Related]
23. [Antineutrophil cytoplasmic antibodies as marker and follow-up parameter of vasculitis and glomerulonephritis].
Wüthrich RP
Praxis (Bern 1994); 1994 Oct; 83(43):1202-6. PubMed ID: 7973270
[TBL] [Abstract][Full Text] [Related]
24. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
25. ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation.
Tse WY; Nash GB; Hewins P; Savage CO; Adu D
Kidney Int; 2005 Jan; 67(1):130-9. PubMed ID: 15610236
[TBL] [Abstract][Full Text] [Related]
26. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
27. Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis.
van Rossum AP; Limburg PC; Kallenberg CG
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S64-8. PubMed ID: 14740429
[TBL] [Abstract][Full Text] [Related]
28. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
29. In vivo latex phagocytosis primes the Kupffer cells and hepatic neutrophils to generate superoxide anion.
Bautista AP; Schuler A; Spolarics Z; Spitzer JJ
J Leukoc Biol; 1992 Jan; 51(1):39-45. PubMed ID: 1311012
[TBL] [Abstract][Full Text] [Related]
30. Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan.
Suzuki Y; Takeda Y; Sato D; Kanaguchi Y; Tanaka Y; Kobayashi S; Suzuki K; Hashimoto H; Ozaki S; Horikoshi S; Tomino Y
Mod Rheumatol; 2010 Feb; 20(1):54-62. PubMed ID: 19821007
[TBL] [Abstract][Full Text] [Related]
31. [Serum antineutrophil cytoplasmic antibodies inhibit the ability of granulocytes to kill C. albicans].
Bartůnková J; Fucíková T; Tesar V; Janatková I; Rychlík I; Sulková S
Cas Lek Cesk; 1994 Aug; 133(15):467-70. PubMed ID: 8082112
[TBL] [Abstract][Full Text] [Related]
32. Outcome of antineutrophil cytoplasmic autoantibodies-positive glomerulonephritis and vasculitis in children: a single-center experience.
Valentini RP; Smoyer WE; Sedman AB; Kershaw DB; Gregory MJ; Bunchman TE
J Pediatr; 1998 Feb; 132(2):325-8. PubMed ID: 9506649
[TBL] [Abstract][Full Text] [Related]
33. [Antineutrophil cytoplasma antibodies (ANCA): clinical indications and experience with these new autoantibodies].
Stupp R; Dubs RW; Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1991 Jul; 121(27-28):1001-7. PubMed ID: 1679257
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
35. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Cockwell P; Brooks CJ; Adu D; Savage CO
Kidney Int; 1999 Mar; 55(3):852-63. PubMed ID: 10027922
[TBL] [Abstract][Full Text] [Related]
37. C-ANCA and p-ANCA positive vasculitis with crescentic glomerulonephritis: the same clinical feature but different immunological pathways?
Grotz W; Röther E; Schollmeyer P
Adv Exp Med Biol; 1993; 336():461-4. PubMed ID: 8296657
[TBL] [Abstract][Full Text] [Related]
38. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.
Jennette JC; Wilkman AS; Falk RJ
Am J Pathol; 1989 Nov; 135(5):921-30. PubMed ID: 2683800
[TBL] [Abstract][Full Text] [Related]
39. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
[TBL] [Abstract][Full Text] [Related]
40. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
